Narrative review: update on immunotherapy and pathological features in patients with bladder cancer
Gaetano Aurilio(European Institute of Oncology), Rodolfo Montironi(Marche Polytechnic University), Alessia Cimadamore(University of Udine), Francesco Massari(Altera (United States)), Marina Scarpelli(Marche Polytechnic University), Liang Cheng(Brown University), Elena Verri(European Institute of Oncology), Antonio López-Beltrán(University of Córdoba), Matteo Santoni(University of Macerata)
Cited by 16
Related Papers
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
|Modern Pathology|2017|404
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289